fda glp-1 warning news november 2025 Beyond the Headlines: Letters to Compounders FDA Issues 30 Warning Letters

Treatments are vehicle (V), cagrilintide (C, 2 nmol/kg), semaglutide (S, 2 nmol/kg), and calorie-restricted to match the weight of the CS rats (weight matched, WM)

The potential antidepressant effect of antidiabetic agents: new insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase

Specifically, liraglutide (administered at 3.0 mg daily) leads to an average weight reduction of 8 percent over 56 weeks, while semaglutide (2.4 mg weekly) achieves a 15 percent decrease within two years

Frontiers in Immunology, 14 , Article 1062045

doi: 10.1186/s10194-021-01234-6 194

Think: bodyweight squats at your kitchen counter, light dumbbells, or resistance bands